4.5 Article

Genetics of congenital adrenal hyperplasia

Journal

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.beem.2008.10.014

Keywords

congenital adrenal hyperplasia; CAH; genetic analysis; CYP21A2; CYP11B1; CYP17A1; HSD3B2; POR

Funding

  1. Wellcome Trust Clinician Scientist Fellow
  2. Medical Research Council Senior Clinical Fellow
  3. Medical Research Council [G116/172] Funding Source: researchfish
  4. MRC [G116/172] Funding Source: UKRI

Ask authors/readers for more resources

Congenital adrenal hyperplasia (CAH) is one of the most common inherited metabolic disorders. It comprises a group Of autosomal recessive disorders Caused by the deficiency of one of four steroidogenic enzymes involved in cortisol biosynthesis or in the electron donor enzyme P450 oxidoreductase (POR) that serves as electron donor to steroidogenic cytochrome P450 (CYP) type II enzymes. The biochemical and clinical phenotype depends oil the specific enzymatic defect and the impairment of specific enzyme activity. Defects of steroid 21-hydroxylase (CYP21A2) and 11 beta-hydroxylase (CYP11B1) only affect adrenal steroidogenesis, whereas 17 alpha-hydroxylase (CYP17A1) and 3 beta-hydroxysteroid dehydrogenase type 2 (HSD3B2) deficiency also impact on gonadal steroid biosynthesis. Inactivating POR gene mutations are the cause of CAH manifesting with apparent combined CYP17A1-CYP21A2 deficiency. P450 oxidoreductase deficiency (ORD) has a complex phenotype including two unique features not observed in any other CAH variant: skeletal malformations and severe genital ambiguity in both sexes. (C) 2008 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available